Filing Flows › Sanuwave Health (SNWV) › Q4 2024
Sanuwave Health (SNWV) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 20, 2025
Sanuwave Health (SNWV) reported revenue of $10.3M for the fourth quarter 2024 (Q4 2024), +48% from a year earlier and +10% from the quarter before. Operating margin was 24.4%, net loss $12.7M (123.5% of revenue).
Sanuwave Health, Q4 2024: revenue $10.3M (+48% year over year), operating margin 24.4%, net loss $12.7M, operating cash flow $741K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.3M | +10% | +48% |
| Operating profit | $2.5M | — | — |
| Net earnings | −$12.7M | — | — |
| Operating cash flow | $741K | -42% | — |
| Free cash flow | $505K | -59% | — |
What changed
Revenue was $10.3M in Q4 2024, up 48% year over year and up 10% from the previous quarter.
Gross margin was 77.9%, up 8.7 points from a year earlier. Operating profit was $2.5M, a 24.4% margin (up 9.6 points year over year). Of the extra revenue versus a year earlier, 45% reached operating profit, above the 15% margin then. Operating expenses grew 45% against revenue growth of 48%. The fastest-growing cost line was General & admin (+65%). The quarter ended with a net loss of $12.7M, narrower than the previous quarter's $21.2M loss. Net interest and other expense of $15.3M was the main reason.
Operating cash flow was $741K. Non-cash charges added back $409K of depreciation and amortization and $1.5M of share-based compensation. Working capital and other items added $11.6M. Capital expenditures of $236K left free cash flow of $505K.
Questions
What was Sanuwave Health's revenue in the fourth quarter 2024?
Sanuwave Health (SNWV) reported revenue of $10.3M for the fourth quarter 2024 (Q4 2024), +48% from a year earlier and +10% from the quarter before.
Was Sanuwave Health profitable in the fourth quarter 2024?
Operating profit was $2.5M (24.4% of revenue) and net loss $12.7M.
Source: Sanuwave Health 10-K on SEC EDGAR.